Approval · Notice of Compliance 14125 · 2013
ACLASTA: Notice of Compliance 14125
Issued February 13, 2013
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 14125
- Date
- February 13, 2013
- Company
- Novartis Pharmaceuticals Canada Inc.Montreal, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Update to the Product Monograph
- Therapeutic class
- Bone metabolism regulator
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| ACLASTA | Not yet assigned | — |
Medicinal ingredients
- ZOLEDRONIC ACID 5.33 MG per BOTTL